Form D · Biotechnology
Relation Therapeutics Inc.
Miami Beach, FL · CIK 0001876828
Offering snapshot reported Dec 9, 2025 · SEC filing
- Reported sold
- $36.2M Offering amount: $36.2M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 21, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 9, 2025 | Initial | $36,175,000 | No comparison | 5 | SEC filing |
| Dec 10, 2024 | Initial | $15,000,000 | No comparison | 1 | SEC filing |
| Jan 19, 2024 | Initial | $40,251,846 | No comparison | 10 | SEC filing |
| Jun 3, 2022 | Initial | $16,000,000 | No comparison | 8 | SEC filing |
| Aug 10, 2021 | Initial | $9,000,000 | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Debt, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-566252
Convertible Promissory Note
Source: Form D, filed Dec 9, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christine Aylward | Director |
| Jim Mellon | Director |
| Jason Pontin | Director |
| Charles Roberts | Director |
| David Roblin | Director, Executive |
| Casey Benjamin Swerner | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
1000 South Pointe Dr. Ph 1605
Miami Beach, FL, 33319
Miami Beach, FL, 33319